Joan Merrill
Impact in
- Rheumatology top 0.01%
- Systemic Lupus Erythematosus Research
- Immunology top 0.05%
- T-cell and B-cell Immunology
- Atherosclerosis and Cardiovascular Diseases
- Immune Cell Function and Interaction
Papers in
- Rheumatology 280
- Systemic Lupus Erythematosus Research 274
- Immunology 87
- T-cell and B-cell Immunology 33
- Atherosclerosis and Cardiovascular Diseases 32
- Immune Cell Function and Interaction 19
- Co-authors
- Daniel J. Wallace (16 shared papers)Michelle Petri (26 shared papers)Richard Alan Furie (22 shared papers)Jill Buyon (29 shared papers)Ellen M. Ginzler (13 shared papers)KENNETH C. KALUNIAN (20 shared papers)William W. Freimuth (8 shared papers)Judith A. James (34 shared papers)
- Journals
- Annals of the Rheumatic Diseases (41 papers)Arthritis & Rheumatology (29 papers)Arthritis Care & Research (25 papers)Lupus Science & Medicine (21 papers)Lupus (14 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Joan Merrill
342 papers receiving 31.3k citations
Joan Merrill's Hit Papers
Peers
Comparison fields: 5 of 143
- Rheumatology 22.6k
- Immunology 12.4k
- Nephrology 2.2k
- Radiology, Nuclear Medicine and Imaging 5.3k
- Hematology 1.7k
Countries citing papers authored by Joan Merrill
This map shows the geographic impact of Joan Merrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Merrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Merrill more than expected).
Fields of papers citing papers by Joan Merrill
This network shows the impact of papers produced by Joan Merrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Merrill. The network helps show where Joan Merrill may publish in the future.
Co-authors
The 25 scholars most cited alongside Joan Merrill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 352 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus Hit paper breakdown → | 2012 | 4104 |
| 2 | A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus Hit paper breakdown → | 2011 | 1336 |
| 3 | American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis Hit paper breakdown → | 2012 | 1137 |
| 4 | Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial Hit paper breakdown → | 2009 | 1121 |
| 5 | Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus Hit paper breakdown → | 2005 | 960 |
| 6 | Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis Hit paper breakdown → | 2005 | 890 |
| 7 | Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus Hit paper breakdown → | 2016 | 700 |
| 8 | The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial Hit paper breakdown → | 2005 | 548 |
| 9 | The frequency and outcome of lupus nephritis: results from an international inception cohort study Hit paper breakdown → | 2015 | 487 |
| 10 | A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus Hit paper breakdown → | 2009 | 470 |
| 11 | Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort Hit paper breakdown → | 2014 | 455 |
| 12 | Predictors of Pregnancy Outcomes in Patients With Lupus Hit paper breakdown → | 2015 | 423 |
| 13 | Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study Hit paper breakdown → | 2016 | 420 |
| 14 | Novel evidence‐based systemic lupus erythematosus responder index Hit paper breakdown → | 2009 | 398 |
| 15 | Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials Hit paper breakdown → | 2012 | 335 |
| 16 | 2010 | 311 | |
| 17 | 2017 | 307 | |
| 18 | 2012 | 306 | |
| 19 | 2002 | 291 | |
| 20 | A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE) Hit paper breakdown → | 2015 | 289 |
About Joan Merrill
Joan Merrill is a scholar working on Rheumatology, Immunology, Radiology, Nuclear Medicine and Imaging, Nephrology and Hepatology, having authored 352 papers that have together received 32.6k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (274 papers), T-cell and B-cell Immunology (33 papers), Atherosclerosis and Cardiovascular Diseases (32 papers), Monoclonal and Polyclonal Antibodies Research (31 papers), Immune Cell Function and Interaction (19 papers), Renal Diseases and Glomerulopathies (14 papers), Cytokine Signaling Pathways and Interactions (13 papers) and Liver Diseases and Immunity (11 papers). The work is most often cited by research in Rheumatology (22.6k citations), Immunology (12.4k citations), Nephrology (2.2k citations), Radiology, Nuclear Medicine and Imaging (5.3k citations) and Hematology (1.7k citations). Joan Merrill has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Daniel J. Wallace, Michelle Petri, Richard Alan Furie, Jill Buyon, Ellen M. Ginzler, KENNETH C. KALUNIAN, William W. Freimuth, Judith A. James, William Stohl and Z. John Zhong. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Arthritis Care & Research, Lupus Science & Medicine and Lupus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.